More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major U.S ...

Cases of exaggerated advertising and illegal sales of anti-obesity drugs such as Wegovy distributed online have exceeded 100 in just the first half of ...

GLP-1 diabetes and weight loss medications like Ozempic, Wegovy and Saxenda are being investigated by the European Union for causing suicidal thoughts, and while drug manufacturer Novo Nordisk denies ...

Ozempic, the diabetes drug that went viral for its ability to help people lose weight and eat less, is back in the news this week. The EU announced that it would investigate Ozempic and Saxenda (a ...

Share on Pinterest Experts say people should expect to be on weight loss medications for a long period of time. NurPhoto/Getty Images Researchers report that more than half of people on weight loss ...

These findings further confirm the safety profile of Saxenda and are comparable to the safety data seen at 56 weeks. Novo Nordisk announced that the Food and Drug Administration (FDA) has approved a ...

PARSIPPANY, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the FDA approval and U.S.

Saxenda is a brand-name injectable solution prescribed for long-term weight management in adults and some children. It contains the active ingredient liraglutide. Saxenda is not safe to use during ...

Saxenda® (liraglutide) injection 3 mg becomes the first FDA-approved therapy to treat obesity in adolescents in more than a decade PLAINSBORO, N.J., Dec. 4, 2020 /PRNewswire/ -- Novo Nordisk today ...

The GLP-1 receptor agonist, which was first approved for adults in December 2014, is now a treatment option for adolescents with obesity ages 12-17 as adjunct to diet and exercise. More specifically, ...